alpha-aminopyridine has been researched along with Day Blindness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, FA; Faut, M; Schauf, CL; Stefoski, D | 1 |
1 other study(ies) available for alpha-aminopyridine and Day Blindness
| Article | Year |
|---|---|
4-Aminopyridine improves clinical signs in multiple sclerosis.
Topics: 4-Aminopyridine; Adult; Aminopyridines; Flicker Fusion; Humans; Ion Channels; Male; Middle Aged; Movement Disorders; Multiple Sclerosis; Neural Conduction; Potassium; Sodium; Vision Disorders; Visual Acuity | 1987 |